Health Canada drug identification number

DIN 02533294 — EMPAVELI 1080 MG

EMPAVELI is a solution of Pegcetacoplan marketed by SWEDISH ORPHAN BIOVITRUM AB (PUBL). The full Pegcetacoplan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02533294
Brand name
EMPAVELI
Active ingredient
Pegcetacoplan
Strength
1080 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Health Canada status
MARKETED
Drug class
Complement inhibitor (C3/C3b-targeted)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.